Browse the full lineup Max Muscle Nutrition products
SAN ANTONIO, July 1, 2025 (Newswire.com) - In This Article, You'll Discover: Understanding the science behind GLP-1 pathways and their role in natural metabolic support for sustainable weight management
Steps to Take Before and During GLP-1 Treatment There are clear, practical actions you can take to protect your vision while using GLP-1 medications

FRIDAY, March 6, 2026 (HealthDay News) -- Treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for type 2 diabetes and obesity is independently associated with a significantly increased five-year risk for osteoporosis, gout, and osteomalacia compared with nonuse, according to a study presented at the annual meeting of the American Academy of Orthopaedic Surgeons, held from March 2 to 6 in New Orleans.Muaaz Wajahath, from the Michigan State University College of Human Medicine in East Lansing, and colleagues evaluated the five-year risk for osteoporosis, gout, and osteomalacia in adults with both type 2 diabetes and obesity treated with GLP-1 RAs (semaglutide, liraglutide, dulaglutide, or exenatide) compared with matched controls (73,483 per group).The researchers found that at five years, patients exposed to GLP-1 RAs had a significantly increased risk for osteoporosis compared with controls (4.1 versus 3.2 percent

Although its benefits are not limited to the skin, it is commonly used to positively affect the skin
The liposomal formulation reduces kidney toxicity while improving targeted drug delivery